Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 457

1.

CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.

Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE.

Hepatology. 2007 May;45(5):1108-17.

PMID:
17464987
2.

Reducing endoplasmic reticulum stress does not improve steatohepatitis in mice fed a methionine- and choline-deficient diet.

Henkel AS, Dewey AM, Anderson KA, Olivares S, Green RM.

Am J Physiol Gastrointest Liver Physiol. 2012 Jul;303(1):G54-9. doi: 10.1152/ajpgi.00052.2012. Epub 2012 May 3.

3.

Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.

Jung YA, Choi YK, Jung GS, Seo HY, Kim HS, Jang BK, Kim JG, Lee IK, Kim MK, Park KG.

Diabetes Res Clin Pract. 2014 Jul;105(1):47-57. doi: 10.1016/j.diabres.2014.04.028. Epub 2014 May 1.

PMID:
24842243
4.

Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.

Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.

Life Sci. 2012 Jan 30;90(5-6):200-5. doi: 10.1016/j.lfs.2011.11.012. Epub 2011 Dec 1.

PMID:
22154902
5.

Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.

Luo ZL, Tang LJ, Wang T, Dai RW, Ren JD, Cheng L, Xiang K, Tian FZ.

J Gastroenterol Hepatol. 2014 Jan;29(1):215-22. doi: 10.1111/jgh.12389.

PMID:
24117897
6.

Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.

Rinella ME, Siddiqui MS, Gardikiotes K, Gottstein J, Elias M, Green RM.

Hepatology. 2011 Nov;54(5):1600-9. doi: 10.1002/hep.24553. Epub 2011 Jul 27.

7.

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.

Dela Peña A, Leclercq I, Field J, George J, Jones B, Farrell G.

Gastroenterology. 2005 Nov;129(5):1663-74.

PMID:
16285964
8.

MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.

Csak T, Bala S, Lippai D, Kodys K, Catalano D, Iracheta-Vellve A, Szabo G.

PLoS One. 2015 Jun 4;10(6):e0129251. doi: 10.1371/journal.pone.0129251. eCollection 2015.

9.

Stress signaling in the methionine-choline-deficient model of murine fatty liver disease.

Soon RK Jr, Yan JS, Grenert JP, Maher JJ.

Gastroenterology. 2010 Nov;139(5):1730-9, 1739.e1. doi: 10.1053/j.gastro.2010.07.046. Epub 2010 Aug 1.

10.

Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.

Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE.

Lab Invest. 2012 May;92(5):713-23. doi: 10.1038/labinvest.2012.45. Epub 2012 Mar 12.

11.

Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Haque JA, McMahan RS, Campbell JS, Shimizu-Albergine M, Wilson AM, Botta D, Bammler TK, Beyer RP, Montine TJ, Yeh MM, Kavanagh TJ, Fausto N.

Lab Invest. 2010 Dec;90(12):1704-17. doi: 10.1038/labinvest.2010.112. Epub 2010 Jun 14.

12.

Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.

Marcolin E, San-Miguel B, Vallejo D, Tieppo J, Marroni N, González-Gallego J, Tuñón MJ.

J Nutr. 2012 Oct;142(10):1821-8. Epub 2012 Aug 22.

13.

Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice.

Yamaguchi K, Itoh Y, Yokomizo C, Nishimura T, Niimi T, Fujii H, Okanoue T, Yoshikawa T.

Lab Invest. 2010 Aug;90(8):1169-78. doi: 10.1038/labinvest.2010.75. Epub 2010 Apr 5.

14.

Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.

Shen B, Yu J, Wang S, Chu ES, Wong VW, Zhou X, Lin G, Sung JJ, Chan HL.

Hepatology. 2008 Feb;47(2):473-83.

PMID:
18157836
15.

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.

J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.

PMID:
21929649
16.

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G.

Hepatology. 2009 Mar;49(3):989-97. doi: 10.1002/hep.22711.

17.

Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.

Greene MW, Burrington CM, Lynch DT, Davenport SK, Johnson AK, Horsman MJ, Chowdhry S, Zhang J, Sparks JD, Tirrell PC.

PLoS One. 2014 Jan 15;9(1):e85848. doi: 10.1371/journal.pone.0085848. eCollection 2014.

18.

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.

Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I.

Hepatology. 2003 Jul;38(1):123-32.

PMID:
12829994
19.

Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.

Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G.

Transl Res. 2012 Jun;159(6):477-86. doi: 10.1016/j.trsl.2011.12.003. Epub 2012 Jan 2.

PMID:
22633099
20.

Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.

Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M Hall P.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):174-82.

PMID:
16706830

Supplemental Content

Support Center